Does Stereoelectroencephalography Add Value in Patients with Lesional Epilepsy?


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 23 05 2022
revised: 25 07 2022
accepted: 26 07 2022
pubmed: 9 8 2022
medline: 18 2 2023
entrez: 8 8 2022
Statut: ppublish

Résumé

Stereoelectroencephalography (SEEG) has gained popularity as an invasive monitoring modality for epileptogenic zone (EZ) localization. The need and indications for SEEG in patients with evident brain lesions or associated abnormalities on imaging is debated. We report our experience with SEEG as a presurgical evaluation tool for patients with lesional epilepsy. A retrospective cohort study was performed of 131 patients with lesional or magnetic resonance imaging abnormality-associated medically refractory focal epilepsy who underwent resections from 2010 to 2017. Seventy-one patients had SEEG followed by resection, and 60 had no invasive recordings. Volumetric analysis of resection cavities from 3T magnetic resonance imaging was performed. Mean lesion and resection volumes for SEEG and non-SEEG were 16.2 (standard deviation [SD] = 29) versus 23.7 cm Seizure outcomes did not correlate with final resection volume after SEEG evaluation. SEEG evaluation presurgically can be used to maintain the efficacy of resection and decrease the volume and subsequent risk of extensive tissue removal. We believe that this technology allows resective surgery to proceed in a subpopulation of patients with lesional epilepsy who may otherwise not have been considered surgical candidates.

Identifiants

pubmed: 35940500
pii: S1878-8750(22)01082-8
doi: 10.1016/j.wneu.2022.07.123
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e196-e203

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Amr Morsi (A)

Department of Neurosurgery, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Akshay Sharma (A)

Department of Neurosurgery, Cleveland Clinic Foundation, Cleveland, Ohio, USA. Electronic address: sharmaa5@ccf.org.

Joshua Golubovsky (J)

Department of Neurosurgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Juan Bulacio (J)

Department of Neurology, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Robert McGovern (R)

Department of Neurosurgery, University of Minnesota Medical Center, Minneapolis VA Medical Center, Minneapolis, Minnesota, USA.

Lara Jehi (L)

Department of Neurology, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

William Bingaman (W)

Department of Neurosurgery, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH